Dianthus Therapeutics Inc (DNTH)
| Sector: | |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
39 |
$34,154,609 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 03 Oct 2023 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
29 Sep 2023 |
24,670 |
13.63 |
336,252 |
| 28 Sep 2023 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
26 Sep 2023 |
30,000 |
13.15 |
394,500 |
| 25 Sep 2023 |
RANDHAWA SIMRAT |
Chief Medical Officer |
22 Sep 2023 |
2,000 |
13.20 |
26,400 |
| 25 Sep 2023 |
RANDHAWA SIMRAT |
Chief Medical Officer |
21 Sep 2023 |
2,000 |
13.20 |
26,400 |
| 21 Sep 2023 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
19 Sep 2023 |
30,000 |
13.20 |
396,000 |
| 13 Sep 2023 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
13 Sep 2023 |
9,367 |
11.76 |
110,156 |
| 13 Sep 2023 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
12 Sep 2023 |
14,887 |
10.85 |
161,524 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock